NCT04816942View on ClinicalTrials.gov

Clinical Efficacy of Early Administration of Convalescent Plasma Among COVID-19 Cases in Egypt

PHASE3CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

April 23, 2020

Primary Completion Date

July 21, 2020

Study Completion Date

October 12, 2020

Conditions
Convalescent PlasmaCovid19ImmunoglobulinsPlasmaEgypt
Interventions
BIOLOGICAL

Convalescent Plasma

Two units of ABO compatible COVID-19 convalescent plasma will be administered.

Trial Locations (1)

00202

Ministry of Health, Cairo

All Listed Sponsors
lead

Ministry of Health and Population, Egypt

OTHER_GOV

NCT04816942 - Clinical Efficacy of Early Administration of Convalescent Plasma Among COVID-19 Cases in Egypt | Biotech Hunter | Biotech Hunter